Andreas Busch is one of the most distinguished research managers in the pharmaceutical industry. After an academic career in physiology and pharmacology in Germany and the USA, the pharmacist moved to industry. From 1999 to 2004, he was Vice President/Global Head of Cardiovascular Research at Sanofi-Aventis in Frankfurt/Main, then until 2017 at Bayer Pharma as a member of the Bayer HealthCare Board of Management and Executive Vice President and Global Head Drug Discovery. From 2018 to 2019 he was Head of R&D and CSO at Shire Pharmaceuticals and since 2019 he has been Chief Innovation Officer, Cyclerion Inc, Switzerland/USA. Andreas Busch has been Professor of Pharmacology at the University of Frankfurt since 2000. He has been and still is a member of numerous advisory boards of research institutions and companies, including Takeda as well as start-up companies such as Omeicos and BerlinCures in Berlin.